From Wikipedia, the free encyclopedia

A mimotope is often a peptide, and mimics the structure of an epitope. Because of this property it causes an antibody response similar to the one elicited by the epitope. An antibody for a given epitope antigen will recognize a mimotope which mimics that epitope. Mimotopes are commonly obtained from phage display libraries through biopanning. Vaccines utilizing mimotopes are being developed. Mimotopes are a kind of peptide aptamers.

When the term mimotope was first coined by Mario Geysen in 1986, [1] it was used to describe peptides mimicking epitopes. However, this concept has been extended to refer peptide mimic of all types of binding sites. As the mimic of binding site, mimotope analysis has been widely used in mapping epitopes, [2] identifying drug target and inferring protein interaction networks. [3] [4] Furthermore, mimotope has also shown its potential in the development of new diagnostics, [5] therapeutics [6] and vaccines. [7] In addition, special affinities mediated by mimotopes to various semiconductors and other materials have shown very encouraging promise in new material and new energy studies. [8] Gathering information on mimotopes into a special database therefore deserves. In 2010, the MimoDB database version 1.0 was released. [9] It had 10716 peptides grouped into 1229 sets. These peptides were extracted from biopanning results of phage-displayed random peptide libraries reported in 571 papers. The MimoDB database has been updated to the current version 2.0 very recently. [10] In version 2.0, it has 15633 peptides collected from 849 papers and grouped into 1818 sets. Besides the core data on panning experiments and their results, broad background information on target, template, library and structure is included. An accompanied benchmark has also been compiled for bioinformaticians to develop and evaluate their new models, algorithms and programs. In addition, the MimoDB database provides tools for simple and advanced searches, structure visualization, BLAST and alignment view on the fly. The experimental biologists can easily use the database as a virtual control to exclude possible target-unrelated peptides. The MimoDB database [11] is freely available.

References

  1. ^ Geysen, HM; Rodda, SJ; Mason, TJ (July 1986). "A priori delineation of a peptide which mimics a discontinuous antigenic determinant". Molecular Immunology. 23 (7): 709–15. doi: 10.1016/0161-5890(86)90081-7. PMID  2432410.
  2. ^ Smith, GP; Petrenko, VA (1997-04-01). "Phage Display". Chemical Reviews. 97 (2): 391–410. doi: 10.1021/cr960065d. PMID  11848876.
  3. ^ Tong, AH; Drees, B; Nardelli, G; Bader, GD; Brannetti, B; Castagnoli, L; Evangelista, M; Ferracuti, S; Nelson, B; Paoluzi, S; Quondam, M; Zucconi, A; Hogue, CW; Fields, S; Boone, C; Cesareni, G (2002-01-11). "A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules". Science. 295 (5553): 321–4. doi: 10.1126/science.1064987. PMID  11743162. S2CID  17604414.
  4. ^ Thom, G; Cockroft, AC; Buchanan, AG; Candotti, CJ; Cohen, ES; Lowne, D; Monk, P; Shorrock-Hart, CP; Jermutus, L; Minter, RR (2006-05-16). "Probing a protein-protein interaction by in vitro evolution". Proceedings of the National Academy of Sciences of the United States of America. 103 (20): 7619–24. Bibcode: 2006PNAS..103.7619T. doi: 10.1073/pnas.0602341103. PMC  1458619. PMID  16684878.
  5. ^ Hsiung, PL; Hardy, J; Friedland, S; Soetikno, R; Du, CB; Wu, AP; Sahbaie, P; Crawford, JM; Lowe, AW; Contag, CH; Wang, TD (April 2008). "Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy". Nature Medicine. 14 (4): 454–8. doi: 10.1038/nm1692. PMC  3324975. PMID  18345013.
  6. ^ Macdougall, IC; Rossert, J; Casadevall, N; Stead, RB; Duliege, AM; Froissart, M; Eckardt, KU (2009-11-05). "A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia". The New England Journal of Medicine. 361 (19): 1848–55. doi: 10.1056/NEJMoa074037. PMID  19890127.
  7. ^ Knittelfelder, R; Riemer, AB; Jensen-Jarolim, E (April 2009). "Mimotope vaccination--from allergy to cancer". Expert Opinion on Biological Therapy. 9 (4): 493–506. doi: 10.1517/14712590902870386. PMC  3049225. PMID  19344285.
  8. ^ Lee, YJ; Yi, H; Kim, WJ; Kang, K; Yun, DS; Strano, MS; Ceder, G; Belcher, AM (2009-05-22). "Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes". Science. 324 (5930): 1051–5. Bibcode: 2009Sci...324.1051L. doi: 10.1126/science.1171541. PMID  19342549. S2CID  32017913.
  9. ^ Ru, B; Huang, J; Dai, P; Li, S; Xia, Z; Ding, H; Lin, H; Guo, F; Wang, X (2010-11-15). "MimoDB: a new repository for mimotope data derived from phage display technology". Molecules (Basel, Switzerland). 15 (11): 8279–88. doi: 10.3390/molecules15118279. PMC  6259156. PMID  21079566.
  10. ^ Huang, J; Ru, B; Zhu, P; Nie, F; Yang, J; Wang, X; Dai, P; Lin, H; Guo, FB; Rao, N (2011-11-03). "MimoDB 2.0: a mimotope database and beyond". Nucleic Acids Research. 40 (1): D271–7. doi: 10.1093/nar/gkr922. PMC  3245166. PMID  22053087.
  11. ^ "The MimoDB database". Archived from the original on 2012-11-16. Retrieved 2011-11-07.


Stub icon

This immunology article is a stub. You can help Wikipedia by expanding it.

Retrieved from " https://en.wikipedia.org/?title=Mimotope&oldid=1187147871"